SOX2 and head and neck squamous cell carcinoma: Evidence against SOX2 as a cancer stem cell marker comes from the report that elevated SOX2 expression in HNSCC is actually associated with a better clinical outcome in this disease [70], while loss of SOX2 expression conversely correlates with poor survival [71].